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YeaZ is involved in a protein network that is essential for bacteria. The crystal
structure of YeaZ from Thermotoga maritima was determined to 2.5 A ˚
resolution. Although this protein belongs to a family of ancient actin-like
ATPases,it appears that it haslost the ability to bind ATP since it lackssome key
structural features that are important for interaction with ATP. A conserved
surface was identiﬁed, supporting its role in the formation of protein complexes.
1. Introduction
yeaZ is an essential gene in many bacteria (Zhang & Lin, 2009), such
as Escherichia coli (yeaZ), Salmonella typhimurium LT2 (yeaZ),
Bacillus subtilis (ydiC), Streptococcus pneumoniae (spr0129), Pseudo-
monasaeruginosa(PA14_16710)andFrancisellanovicida(FTN_1148).
A genome-wide study of the E. coli interaction network revealed that
YeaZ forms a complex with YgjD (Butland et al., 2005). A recent
study further demonstrated that E. coli YeaZ can interact with either
YgjD or YjeE, with YgjD as the preferred partner, suggesting that
YeaZ is part of a protein network that may be involved in DNA
metabolism and cell division (Handford et al., 2009). YgjD is
homologous to Kae1 (kinase-associated endopeptidase 1), a com-
ponent of the yeast KEOPS/EKC complex (kinase, endopeptidase
and other proteins of small size/endopeptidase-like and kinase
associated to transcribed chromatin) that is necessary for telomere
maintenance and transcription of essential eukaryotic genes
(Downey et al., 2006; Kisseleva-Romanova et al., 2006). Kae1 and its
homologs belong to the ASKHA (acetate and sugar kinase/Hsp70/
actin) superfamily (Mao et al., 2008; Hecker et al., 2007, 2008). Recent
crystal structures of YeaZs from E. coli (EcYeaZ), S. typhimurium
(StYeaZ; Jeudy et al., 2005; Nichols et al., 2006) and Thermotoga
maritima (TmYeaZ; this study) indicate that YeaZ is structurally
related to Kae1 and thus belongs to the same superfamily.
Here, we report the 2.5 A ˚ resolution crystal structure of TmYeaZ
from T. maritima (TM0874) in the light of current knowledge of the
involvement of YeaZ in protein complexes, which was not available
when the original StYeaZ structure was reported (Nichols et al.,
2006). The structure of TmYeaZ was determined using the high-
throughput pipeline of the Joint Center for Structural Genomics
(JCSG; Lesley et al., 2002) as part of the National Institute of
General Medical Sciences’ Protein Structure Initiative (PSI; http://
www.nigms.nih.gov/Initiatives/PSI/). The tm0874 gene of T. maritima
encodes a protein with a molecular weight of 22 986 Da (residues
1–206) and a calculated isoelectric point of 6.35.
2. Materials and methods
2.1. Protein production and crystallization
The gene encoding TmYeaZ (GenBank AAD35955.1; gi:4981408;
Swiss-Prot Q9WZX7) was ampliﬁed by polymerase chain reaction
(PCR) from T. maritima genomic DNAusing PfuTurbo (Stratagene)
and primers corresponding to the predicted 50 and 30 ends (forward
primer, 50-ATGAACGTTCTGGCACTCG-30; reverse primer, 50-CT-
CTTAATTAAGTCGCGTTAGCCCCTTTTCTTTTTTTCCCAG-30).The PCR product was cloned into plasmid pMH4 (developed at the
JCSG), which encodes an expression and puriﬁcation tag (MGS-
DKIHHHHHH) at the amino-terminus of the full-length protein.
The cloning junctions were conﬁrmed by DNA sequencing. Protein
expression was performed in a selenomethionine-containing medium
using E. coli strain GeneHogs (Invitrogen). Lysozyme was added to
the culture at the end of fermentation to a ﬁnal concentration of
250 mgm l
 1 and the cells were harvested. After one freeze–thaw
cycle, the cells were sonicated in lysis buffer [50 mM Tris–HCl pH 7.9,
50 mM NaCl, 10 mM imidazole, 1 mM tris(2-carboxyethyl)phosphine
hydrochloride (TCEP)] and the lysate was clariﬁed by centrifugation
at 32 500g for 30 min. The soluble fraction was applied to nickel-
chelating resin (GE Healthcare) pre-equilibrated with lysis buffer,
the resin was washed with wash buffer [50 mM Tris–HCl pH 7.9,
300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP]
and the protein was eluted with elution buffer [20 mM Tris–HCl pH
7.9, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP]. The eluate
was diluted tenfold to 45 ml with buffer Q [20 mM Tris–HCl pH 7.9,
5%(v/v) glycerol, 1 mM TCEP] containing 50 mM NaCl and loaded
onto a 6 ml Resource Q column (GE Healthcare) pre-equilibrated
with the same buffer. A linear gradient of 50–500 mM NaCl in buffer
Q was used to elute the protein and the appropriate fractions were
pooled. The protein was concentrated to 1 ml by centrifugal ultra-
ﬁltration (Millipore) and diluted to 15 ml with crystallization buffer
(20 mM Tris–HCl pH 7.9, 150 mM NaCl, 1 mM TCEP). This process
was repeated two more times, resulting in a 3375-fold buffer
exchange. The protein was then concentrated to 14 mg ml
 1 for
crystallization, with its concentration being determined using
Coomassie Plus Protein Assay Reagent (Pierce). To determine its
oligomeric state, we analyzed TmYeaZ using a 1   30 cm Superdex
200 column (GE Healthcare) coupled with miniDAWN static light-
scattering and Optilab differential refractive-index detectors (Wyatt
Technology). The mobile phase consisted of 20 mM Tris–HCl pH 7.9,
150 mM NaCl and 0.02%(w/v) sodium azide. The molar mass was
calculated using ASTRA 5.1.5 software (Wyatt Technology). The
protein was crystallized using the nanodroplet vapor-diffusion
method (Santarsiero et al., 2002) with standard JCSG crystallization
protocols (Lesley et al., 2002). Sitting drops consisting of 200 nl
protein solution and 200 nl crystallization reagent above a 50 ml
reservoir were used. Initial screening for diffraction was carried out
using the Stanford Automated Mounting system (SAM; Cohen et al.,
2002) at the Stanford Synchrotron Radiation Lightsource (SSRL;
Menlo Park, California, USA). The crystal used for structure solution
was obtained in 10%(v/v) 2-methyl-2,4-pentanediol (MPD) and
0.1 M citrate pH 4.0 at 277 K. A rectangular, plate-shaped crystal
( 50   30   15 mm) was harvested after 10 d. For cryoprotection,
additional MPD was added to the crystal, bringing the ﬁnal concen-
tration to 25%(v/v). Diffraction images were indexed in space group
C222.
2.2. Data collection, structure solution and refinement
Multi-wavelength anomalous diffraction (MAD) data were
collected at SSRL on beamline 11-1 at wavelengths corresponding to
the high-energy remote ( 1) and inﬂection ( 2) of a selenium MAD
experiment. The data sets were collected at 100 K using an ADSC
Q315 detector. The MAD data were integrated and reduced using
XDS and then scaled using the program XSCALE (Kabsch, 1993).
Selenium sites were located with SHELXD (Sheldrick, 2008) and
reﬁned using autoSHARP (Bricogne et al., 2003). Phase reﬁnement
and automatic model building was performed with RESOLVE
(Terwilliger, 2003). Model completion and reﬁnement were per-
formed with Coot (Emsley & Cowtan, 2004) and REFMAC (Winn et
al., 2003). Loose NCS restraints for both main chains and side chains
(positional and thermal weights of 5.0 and 10.0, respectively) were
applied between the two monomers. Each monomer was deﬁned as a
TLS group. Experimental MAD phases in the form of Hendrickson–
Lattman coefﬁcients were used as restraints during reﬁnement. CCP4
programs were used for data conversion and other calculations
(Collaborative Computational Project, Number 4, 1994). Data-
processing and reﬁnement statistics are summarized in Table 1.
2.3. Validation, deposition and figures
The quality of the reﬁned structure was analyzed using the JCSG
Quality Control server, which veriﬁes the stereochemical quality of
the model using AutoDepInputTool (Yang et al., 2004), MolProbity
(Lovell et al., 2003) and WHATIF 5.0 (Vriend, 1990), the agreement
between the atomic model and the data using SFCHECK 4.0
(Vaguine et al., 1999) and RESOLVE (Terwilliger, 2003), the protein
sequence using ClustalW (Thompson et al., 1994), the atomic occu-
pancies using MOLEMAN2 (Kleywegt, 2000) and the consistency of
NCS pairs. It also evaluates the difference in Rcryst/Rfree, expected
Rfree/Rcryst and maximum/minimum B values by parsing the reﬁne-
ment log ﬁle and PDB header. Analysis of the crystal packing was
performed using the PISA server (Krissinel & Henrick, 2007). The
sequences used for Fig. 3 are the top hits from a BLAST search
(Altschul et al., 1997) against the nonredundant protein-sequence
database using TmYeaZ as a probe; only sequences with lengths
between 180 and 250 residues were retained for the analysis (237
sequences). Multiple sequence alignments were performed using
MAFFT (Katoh et al., 2005). Mapping of sequence conservation onto
structural communications
Acta Cryst. (2010). F66, 1230–1236 Xu et al.   YeaZ 1231
Table 1
Summary of crystal parameters, data collection and reﬁnement statistics for
TmYeaZ (PDB code 2a6a).
Values in parentheses are for the highest resolution shell.
 1 MADSe  2 MADSe
Space group C222
Unit-cell parameters (A ˚ ) a = 93.27, b = 217.11, c = 51.95
Data collection
Wavelength (A ˚ ) 0.9184 0.9794
Resolution range (A ˚ ) 29.2–2.50 (2.64–2.50) 29.2–2.58 (2.72–2.58)
No. of observations 66857 60100
No. of reﬂections 18685 16886
Completeness (%) 99.5 (99.9) 98.7 (93.0)
Mean I/ (I) 12.3 (2.3) 12.7 (2.5)
Rmerge on I† 0.06 (0.55) 0.06 (0.48)
Model and reﬁnement statistics
Resolution range (A ˚ ) 29.2–2.5
No. of reﬂections (total) 18685
No. of reﬂections (test) 955
Completeness (%) 99.5
Data set used in reﬁnement  1 MADSe
Cutoff criterion |F|>0
Rcryst‡ 0.191
Rfree§ 0.235
Stereochemical parameters
Restraints (r.m.s. observed)
Bond lengths (A ˚ ) 0.018
Bond angles ( ) 1.69
Average isotropic B value (A ˚ 2) 62.7}
ESU†† based on Rfree value (A ˚ ) 0.24
Protein residues/atoms 381/2889
Water molecules/ligands 23/2
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ.‡ Rcryst =
P
hkl
   jFobsj 
jFcalcj
   =
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed structure-factor
amplitudes, respectively. § Rfree is the same as Rcryst but for 5.0% of the total reﬂections
chosen at random and omitted from reﬁnement. } This value represents the total B
that includes TLS and residual B components. †† Estimated overall coordinate error
(Cruickshank, 1999).the protein was performed by CONSURF (Landau et al., 2005).
Fig. 1(d) was generated using ESPript (Gouet et al., 2003) with
secondary structures assigned by DSSP (Kabsch & Sander, 1983).
Fig. 3(c) was generated using WEBLOGO (Crooks et al., 2004). All
other ﬁgures were prepared with PyMOL (DeLano Scientiﬁc).
3. Results and discussion
The selenomethionine derivative of full-length TmYeaZ with an
N-terminal His tag was expressed in E. coli and puriﬁed by metal-
afﬁnity chromatography. The crystal structure of TmYeaZ was
determined in space group C222 at 2.5 A ˚ resolution using the MAD
method. The ﬁnal TmYeaZ model includes a dimer (residues 1–193
for chain A and 0–187 for chain B (residue 0 is the last residue of the
His tag; the remainder of the His tag is disordered; Figs. 1a and 1b),
two unknown ligands (UNL), which were modeled as discrete O
atoms without geometry restraints, and 23 water molecules in the
asymmetric unit. The two independent molecules in the asymmetric
unit (A, B) are similar to each other, with a root-mean-square
difference of 0.53 A ˚ for 187 aligned C
  atoms. The C-termini (194–
206 of chain A and 188–206 of chain B) were not modeled owing to a
lack of interpretable electron density. The Matthews coefﬁcient (VM;
Matthews, 1968) for TmYeaZ is 3.25 A ˚ 3 Da
 1 and the estimated
solvent content is 61.9%. The Ramachandran plot produced by
MolProbity shows that 95.5 and 99.5% of the residues are in favored
and allowed regions, respectively. The two Ramachandran outliers
(residues 115 and 151 of chain A) are located in regions of poor
electron density. TmYeaZ is composed of nine  -strands ( 1– 9), six
 -helices ( 1– 6) and four 310-helices ( 1– 4). The total  -sheet,
 -helical and 310-helical content is 31.6, 32.6 and 6.2%, respectively.
The molecular weight of TmYeaZ in solution was determined to be
52 720 Da by analytical size-exclusion chromatography in combina-
tion with static light scattering. As a monomer of His-tagged SeMet-
TmYeaZ would have a calculated molecular weight of 24 404 Da, it is
likely that TmYeaZ exists as a dimer in solution. Analysis of the
crystal packing suggests two possible modes of dimerization. In the
ﬁrst possibility (Fig. 1b), the two independent monomers in the
asymmetric unit would form a dimer (AB dimer) with a buried
surface of 1240 A ˚ 2 per monomer (12.7% of the monomer surface
structural communications
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Figure 1
Crystal structure of TmYeaZ (TM0874) from T. maritima.( a) Ribbon diagram of TmYeaZ monomer. Helices  1– 6 and  -strands  1– 9 are labeled. (b) A dimer of
TmYeaZ consisting of two protomers in the asymmetric unit. (c) Alternate dimer formed by the crystallographic twofold axis. (d) Sequence alignment between TmYeaZ
(PDB code 2a6a), EcYeaZ (PDB code 1okj) and StYeaZ (PDB code 2gel). The secondary structure and sequence numbering of TmYeaZ are shown in the top row. The
secondary structure of StYeaZ is shown in the bottom row.area). The  3 strands from the two N-terminal domains pack together
in an antiparallel manner to form an extended  -sheet. In the alter-
nate mode, in which two dimers (A2 and B2) are formed by the
crystallographic twofold axis [Fig. 1c, only the B2 (B–B0) dimer is
shown], the  1 and  2 helices of their N-terminal domains are packed
into a four-helix bundle, which generates a V-shaped dimer. This
dimer interface buries a surface area of 870 A ˚ 2 per monomer for the
B2 dimer (9% of the B monomer surface area) and 565 A ˚ 2 per
monomer for the A2 dimer (5.7% of the A monomer surface area).
Although this second type of dimer interaction is weaker, it is
interesting to note that a similar mode of dimerization is conserved in
the crystal structures of both StYeaZ and EcYeaZ (Nichols et al.,
2006).
TmYeaZ belongs to the actin-like ATPase superfamily, which
typically contains a duplication of ribonuclease H-like domains
(Andreeva et al., 2004). In TmYeaZ, the ﬁrst ribonuclease H-like
domain is composed from both the N-terminus (residues 1–100) and
the C-terminus (residues 160–193) of the protein. The second domain
(residues 101–159) can be superimposed onto the N-terminal portion
of the ﬁrst domain with an r.m.s.d. of 3.18 A ˚ for 47 aligned C
  atoms;
however, it lacks the segment corresponding to the  1– 4 region of
the ﬁrst domain. The top hits from DALI (Holm & Sander, 1995)
identiﬁed two bacterial YeaZ proteins: EcYeaZ (PDB code 1okj;
Z = 21.0, r.m.s.d. = 2.1 A ˚ for 188 aligned C
  atoms, 22% sequence
identity; C. Abergel, S. Jeudy & J. M. Claverie, unpublished work)
and StYeaZ (PDB code 2gel; Z= 20.6, r.m.s.d.= 2.3 A ˚ for 187 aligned
C
  atoms, 21% sequence identity; Nichols et al., 2006). Since detailed
structural comparisons of these YeaZ homologs and ASKHA
proteins have been reported previously (Nichols et al., 2006), we only
brieﬂy summarize the new results related to TmYeaZ. A structure-
based sequence alignment of YeaZs is shown in Fig. 1(d). Compared
with the other two YeaZs, TmYeaZ lacks the 20-residue    insertion
between  9 and  5 in the second domain. Overall, the substantial
structural similarities among these YeaZs suggest a common function.
TmYeaZ also displays strong structural similarities to Kae1, espe-
cially in the ﬁrst domain (PDB code 2ivp; r.m.s.d. = 2.1 A ˚ for 110
aligned C
  atoms, 18% sequence identity; Hecker et al., 2007). The
second domain of Kae1 has an additional helical domain inserted
between  8 and  4 of TmYeaZ, as well as an    insert between  9
and  5. Most strikingly, the orientation of the second domain of
YeaZs with respect to the ﬁrst domain differs signiﬁcantly from that
of Kae1 and other ASKHA proteins (Fig. 2a; Hecker et al., 2007;
Nichols et al., 2006). We were unable to identify a conserved ATP-
binding site at the domain interface, although it has previously been
proposed that YeaZ may still bind nucleotides through signiﬁcant
rearrangement of its two domains (Nichols et al., 2006). YeaZs also
lack the metal-binding motif of Kae1. In ASHKA proteins, the
second domain plays an important role in stabilizing the adenosine
base of the bound ATP. However, the substructure that interacts with
the base in Kae1 is absent in TmYeaZ (Fig. 2b). Thus, it is unclear
how a suitable environment for nucleotide binding could be assem-
bled within TmYeaZ.
EcYeaZ forms a stable complex with YgjD, but can also interact
with the YjeE ATPase in a mutually exclusive manner (Handford et
al., 2009). In order to identify sites that are potentially important for
TmYeaZ function, we studied the sequence-conservation pattern of
the YeaZ and Kae1 families in the context of the YeaZ structures
(Fig. 3). The most prominent common feature of these proteins is the
prevalence of the sequence motif GPGXXTGXR located at the
N-terminus of a helix ( 2 of TmYeaZ). This motif, which is remi-
niscent of a phosphate-binding motif, is close to the ATP-binding site
in Kae1, but does not directly interact with ATP in Kae1. The argi-
nine in this motif is exposed on the face of a helix in both Kae1 and
YeaZs. Other conserved residues of the YeaZ homologs that are
clustered around this motif include residues from the N-terminus of
 1 (Lys32 and His33), the C-terminus of  1 (Asp7 and Thr8), the C-
terminal portion of 6 (Arg112, Ala113 and Arg114),  7 (Tyr119) and
the C-terminus of  6 (Pro188, Tyr190 and Gln192). This cluster of
conserved residues indicates that this region is likely to be directly
involved in the function of YeaZ. In TmYeaZ, a prominent positively
charged electrostatic surface overlaps with this conserved surface;
however, this feature is not conserved in EcYeaZ or StYeaZ. We
speculate that part of or the entire conserved surface is involved in
mediating protein–protein interactions between YeaZ and YgjD
(TM0145) or YjeE (TM1632) in T. maritima.
It is worth noting that the conserved residues in  6 and  1o f
TmYeaZ display large conformational differences compared with
StYeaZ and EcYeaZ (Fig. 4a). The residues corresponding to  6o f
TmYeaZ are not in a helical conformation in StYeaZ and EcYeaZ
despite being highly conserved in primary sequence. In the crystal
structures of EcYeaZ and StYeaZ,  1 is packed more closely to  2i n
an arrangement similar to that in Kae1.  1 and  2 are also stabilized
structural communications
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Figure 2
Structural comparisons of TmYeaZ and Kae1 (PDB code 2ivp). (a) Stereoview of the superposition of TmYeaZ (cyan) and Kae1 (red). (b) Superposition of the second
domain of TmYeaZ (green) and the second domain of Kae1 (magenta). ATP bound to Kae1 is shown in stick representation.by a hydrogen bond involving a conserved histidine (His34) from the
N-terminus of  1 and the  1– 2 loop and a potential disulﬁde bond
between two cysteines (Cys13 and Cys30 in StYeaZ). A corre-
sponding interaction was not observed in TmYeaZ, since  1 is more
distant from  2 and, as a result, the conserved histidine (His33 in
TmYeaZ) is exposed and further from the conserved cluster (Fig. 4a).
The wider gap between  1 and  2 in TmYeaZ partially exposes the
hydrophobic interior of the  1 and  2 strands, which are buried in the
other YeaZ structures. Interestingly, a section of unaccounted-for
electron density was observed in the resulting exposed groove of
TmYeaZ and was modeled as an unidentiﬁed ligand (UNL; Fig. 4b).
This UNL could be a lipid or MPD, but it was not possible to
unambiguously identify its nature. As the UNL is close to the
conserved surface identiﬁed above, it may have functional implica-
tions; an alternative explanation that cannot be ruled out at present is
that it is a crystallization artifact. Overall, the large conformational
differences in these conserved residues may indicate that they are
ﬂexible in solution and may adopt a more rigid conformation when
TmYeaZ is bound in the complex.
One of the dimers observed in the crystal lattice is likely to have
physiological signiﬁcance. EcYeaZ also dimerizes (Handford et al.,
2009). However, it is not clear from the crystal structure which one of
structural communications
1234 Xu et al.   YeaZ Acta Cryst. (2010). F66, 1230–1236
Figure 3
Mapping of conserved regions onto the TmYeaZ structure. (a) Ribbon representation of TmYeaZ colored by sequence conservation of 237 homologs of TmYeaZ. The most
conserved residues are shown in magenta and the least conserved residues in cyan. The most conserved regions of the structure are marked 1, 2 and 3, respectively. (b)
Molecular surface of TmYeaZ colored by sequence conservation. The orientation of the molecule is the same as in Fig. 2(a). (c) A sequence logo representation of the three
most conserved regions in YeaZ. A logo consists of stacks of symbols, one stack for each position in the sequence. The overall height of the stack indicates the sequence
conservation at that position, while the height of the symbols within the stack indicates the relative frequency of each amino or nucleic acid at that position. (d, e) Molecular
surface of the AB (d) and A2 (or B2)( e) dimers colored by sequence conservation, as in Figs. 1(b) and 1(c).the two possible dimers represents the physiologically relevant form.
The mode of dimerization affects the placement and exposure of the
conserved surface identiﬁed above. The conserved surfaces of each
monomer are fully exposed at either end in the AB dimer, while they
are clustered together in the A2 (or B2) dimer (Figs. 3d and 3e). The
A2 dimer imposes very strict steric restrictions on the size of and the
mode of interaction with its partners. Based on the size of interface,
the AB dimer may be more stable. Given that the ﬁrst domains of
YgjD and YeaZ are structurally similar, the observed crystal-packing
interaction seen in the A2 dimer may mimic the complex between
YeaZ and YgjD.
The speciﬁc function of YeaZ is still unknown. In Gram-positive
organisms such as B. subtilis, YdiB (the YjeE homolog), YdiC (the
YeaZ homolog), YdiD and YdiE (the Kae1 or Gcp homolog) are
located within the same operon. The four corresponding proteins in
T. maritima [TM1632 (TmYjeE), TM0874 (TmYeaZ), TM0577 and
TM0145 (TmYgjD)] are dispersed across the genome. It has been
suggested that YeaZ mediates the proteolysis of YgjD (Handford et
al., 2009). However, no active site mimicking those of known pepti-
dases can be identiﬁed based on the crystal structure. Thus, its
mechanism remains unclear. YeaZ may fulﬁll its function by contri-
buting one or more critical functional groups to a bipartite active site
in a heterodimeric complex with YgjD or YjeE. Since YgjD and YjeE
are both ATPases, it is possible that YeaZ functions as an ATPase
inhibitor or activator. Further experiments are needed to elucidate
the function of YeaZ and its possible partners.
4. Conclusions
The crystal structure of TmYeaZ (TM0874), a YeaZ homolog that is
an essential protein in bacteria, has been elucidated. Based on its
structure, TmYeaZ by itself is not likely to be an ATPase owing to the
absence of a clearly deﬁned ATP-binding site. A potential interface
for mediating protein–protein interaction was identiﬁed. It remains
possible that TmYeaZ may play a role in nucleotide binding or
hydrolysis in a complex involving YgjD.
Essential gene products are excellent targets for antibacterial
drugs. Unlike Kae1, YeaZ could be a potential drug target since it
only seems to be present in bacteria. The crystal structure and the
information presented here should be valuable for further
biochemical characterization of this important bacterial protein.
Additional information about TmYeaZ is available from TOPSAN
(Krishna et al., 2010) http://www.topsan.org/explore?PDBid=2a6a.
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